However, for investors that can stomach the added volatility, PSCH is worth the lofty multiples. ETF issuers are ranked based on their AUM-weighted average 3-month return of their ETFs with exposure to Biotechnology. The following is a list of 25 biotech companies, ranked by their market cap as of September 6, 2017 as furnished by

Read more…